期刊
MOVEMENT DISORDERS
卷 19, 期 10, 页码 1256-1258出版社
WILEY-LISS
DOI: 10.1002/mds.20194
关键词
amantadine; levodopa-induced dyskinesias; GTP cyclohydrolase I deficiency
Amantadine suppressed severe levodopa-induced choreic dyskinesia, which developed at initiation of levodopa therapy, in two siblings manifesting dystonia with motor delay phenotype of GTP cyclohydrolase 1 deficiency caused by compound heterozygous GCH1 mutations. Our finding suggests a beneficial effect of amantadine on this type of dyskinesia frequently observed in relatively severe dopamine-deficient metabolic disorders. (C) 2004 Movement Disorder Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据